• Business Update: Motif Bio

News & Views

Business Update: Motif Bio

Jan 05 2021

Reclassified as an AIM Rule 15 cash shell, following completion of restructuring approved by shareholders in November 2019, Motif Bio plc (AIM: MTFB), announces a business update regarding progress towards completing a reverse take-over pursuant to AIM Rule 14 (“RTO”).

The Company is currently advancing the necessary work streams to complete the RTO process with a UK based candidate in the healthcare sector.  The Board expects to provide shareholders with a further update during the second half of January.

Following its reclassification as an AIM Rule 15 cash shell in January 2020, the Company is required to make an acquisition which constitutes a RTO by 28 January 2021, failing which the Company's admission to trading on AIM may be cancelled. At this stage, there can be no assurance that the Company will be able to complete this or any other RTO transaction.

The person responsible for the release of this announcement on behalf of Motif Bio is Jonathan Gold, President and Chief Business Officer.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.


Digital Edition

LabAsia Buyers Guide 2021

October 2021

In this Edition Articles - Applications of Newly Developed 2.7 μm Porous Graphitic Carbon Particles in U/HPLC - Improve sensitivity and decrease matrix effects in pesticide residue analysis...

View all digital editions

Events

ASMS Conference - NEW DATES

Oct 31 2021 Philadelphia, PA, USA

analytica Lab Africa -CANCELLED

Nov 02 2021 Johannesburg, South Africa

Lab Innovations 2021

Nov 03 2021 Birmingham, UK

ISPPP 2021

Nov 07 2021 Porto, Portugal

JASIS 2021

Nov 08 2021 Chiba, Japan

View all events